Literature DB >> 8953688

Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin.

C Pers1, P Søgaard, L Pallesen.   

Abstract

We report on a strain of Salmonella enteritidis which was found to be resistant to both ciprofloxacin and beta-lactams and chloramphenicol in a patient treated with ciprofloxacin for a splenic abscess. We conclude that in invasive infections such as a splenic abscess caused by Salmonella, early surgical intervention is important. Multiple-drug-resistant strains of Salmonella may be selected by treatment with ciprofloxacin alone.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8953688     DOI： 10.3109/00365549609037954

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  8 in total

1.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

2.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.

Authors:  Maria Sjölund-Karlsson; Rebecca L Howie; John A Crump; Jean M Whichard
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

4.  Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

Authors:  A Hakanen; P Kotilainen; J Jalava; A Siitonen; P Huovinen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates.

Authors:  R A Walker; N Saunders; A J Lawson; E A Lindsay; M Dassama; L R Ward; M J Woodward; R H Davies; E Liebana; E J Threlfall
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

6.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

7.  In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.

Authors:  Pirkko Kotilainen; Susa Pitkänen; Anja Siitonen; Pentti Huovinen; Antti J Hakanen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-09-05       Impact factor: 3.944

Review 8.  Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.

Authors:  Natassja G Bush; Isabel Diez-Santos; Lauren R Abbott; Anthony Maxwell
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.